New structure of key protein holds clues for better drug design — ScienceDaily

Scientists have peered deep into the heart of a key protein used in drug design and discovered dynamic structural features that may lead to new ways to target diseases. The protein, called the A2A adenosine receptor (A2aAR), is a member of the G-protein-coupled receptor (GPCR) family, which are the targets of roughly 40 percent of all approved pharmaceuticals.

Source: New structure of key protein holds clues for better drug design — ScienceDaily

Leave a Reply

Name *
Email *
Website